...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zenith trial partners

,,its no wonder free speeeeeeech is a rare commodity today,,,surely varying perspectives can all get along,,,,and the reality is most likely none of what we think is true will turn out to be so!!

....and I get a chuckle out of every post that will say,,and "Don said",,,,good grief what does it take to understand that this individual is incapabale of passing along accurate information,,,,,!!..everything points to being a promotional tactic out of some manual in hindsight,,,,,!

 

 

 

Share
New Message
Please login to post a reply